Ocrevus 300 MG/1 ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FX1NA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,638
Award facts
- Contract value 100% obligated
- $25,637.70 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $25,637.70 delivery order to Amerisourcebergen Drug Corp on March 23, 2026, for Ocrevus 300 mg/1 mL pharmaceutical supply.
The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 supporting global pharmaceutical supply to military healthcare programs. Place of performance is Conshohocken, Pennsylvania. The order carries a firm fixed price and reached ultimate completion on March 23, 2026.
Quick answers
Who was awarded contract SPE2DR26FX1NA?
SPE2DR26FX1NA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 23, 2026.
How much is contract SPE2DR26FX1NA worth?
The government has obligated $25,638 on SPE2DR26FX1NA.
Is contract SPE2DR26FX1NA an order under another contract?
Yes. SPE2DR26FX1NA is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FX1NA competed?
The extent of competition for SPE2DR26FX1NA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award